Informationssysteme GmbH is a privately held software vendor focusing on technology concerning information, communication and recognition.
Informationssyteme GmbH is focused on information, communication and recognition technologies.
The implants are part of a 12 patient evaluation designed to confirm the performance of the Axonics rechargeable SNM System as an aid in the treatment of the symptoms of Fecal Incontinence.
To date, over 25 patients have been successfully implanted at leading medical centers in the Netherlands, Belgium, France and the UK as part of a post-market clinical follow-up study (RELAX-OAB) designed to confirm the performance of the Axonics SNM System as an aid in the treatment of the symptoms of Overactive Bladder.
The Axonics patent portfolio represents technology developed under license from the Alfred Mann Foundation and technology internally developed by Axonics.
The Axonics neuromodulation platform includes, among other innovations, a miniaturized rechargeable implantable neuromodulation stimulator (IPG) that is approximately one-fourth the size of smallest currently marketed rechargeable IPGs and can be directed toward numerous clinical applications, according to the company.
Axonics is now using its technology on cruise ships.
Axonics managing director Philip Morgan said, 'The process is more effective and much faster than conventional systems, taking only a few seconds to treat wastewater, instead of hours or even days with chemical and biological methods.
The United States Patent and Trademark Office has granted US-based medical device maker Axonics Modulation Technologies, Inc a new US patent relating to its implantable neuromodulation technology for the treatment of urinary and fecal dysfunction, the company said on Monday.
Axonics' patent portfolio represents technology developed under license from the Alfred Mann Foundation and technology internally developed by Axonics.
The driving force behind Axonics
is scientist turned businessman Phil Morgan.
US-based medical device maker Axonics
Modulation Technologies, Inc has received magnetic resonance imaging conditional labeling approval in Europe for its SNM System, the company said.
Scientist-turned-businessman Phil Morgan of Gorseinon, Swansea, dreamed up the so-called Axonics
process of using electrical charges to rapidly remove even the most virulent chemicals from drinking and waste water.
US-based implantable neuromodulation technology developer Axonics
Modulation Technologies, Inc.
M2 PHARMA-May 9, 2016-Neuromodulation System Developer Axonics
Granted Six US Patents